Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation

NARecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

August 12, 2025

Primary Completion Date

October 1, 2028

Study Completion Date

October 1, 2028

Conditions
Chronic Hepatitis B Virus
Interventions
OTHER

blood sample HBV patient

"During a boold sample at only one follow up visit:~* 3 tubes EDTA 10 ml per patient~* 1 tube Paxgene 1ml~* 2 dry tube per patient"

OTHER

blood sample healthy volunteers

"* 3 tubes EDTA ideally age and sex matched to CHB patient.~* 1 tube Paxgene 1ml~* 2 dry tube"

Trial Locations (3)

69004

NOT_YET_RECRUITING

Hospice civils de Lyon, Lyon

87042

RECRUITING

Centre d'Investigation Clinique, Limoges

RECRUITING

Limoges University Hospital, Limoges

All Listed Sponsors
collaborator

National Agency for Research on AIDS and Viral Hepatitis (ANRS)

OTHER

lead

University Hospital, Limoges

OTHER

NCT06853886 - Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation | Biotech Hunter | Biotech Hunter